Search research articles
Contact Us
Filters
Showing results (71-80 of 787) with videos related to
Page
of 79
Sort By:
Clinical Biochemistry
|
December 1, 1989
A double monoclonal time-resolved immunofluorometric assay of carcinoembryonic antigen in serum
V Bhayana, E P Diamandis
Biological Chemistry
|
July 17, 2008
Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions
Azza Eissa, Eleftherios P Diamandis
Nature Clinical Practice. Oncology
|
August 13, 2008
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Vathany Kulasingam, Eleftherios P Diamandis
The Urologic Clinics of North America
|
May 1, 1997
Nonprostatic sources of prostate-specific antigen
E P Diamandis, H Yu
Clinical Chemistry and Laboratory Medicine
|
September 25, 2015
Theranos phenomenon - part 2
Michelle Li, Eleftherios P Diamandis
BMC Medicine
|
August 18, 2017
Circulating tumor DNA for personalized lung cancer monitoring
Clare Fiala, Eleftherios P Diamandis
F1000Research
|
March 24, 2018
Hubris and Sciences
Eleftherios P Diamandis, Nick Bouras
F1000Research
|
January 16, 2018
Can circulating tumor DNA be used for direct and early stage cancer detection?
Eleftherios P Diamandis, Clare Fiala
Clinical Chemistry and Laboratory Medicine
|
March 12, 2020
Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection
Clare Fiala, Eleftherios P Diamandis
BMC Medicine
|
October 29, 2020
Mutations in normal tissues-some diagnostic and clinical implications
Clare Fiala, Eleftherios P Diamandis
Page
of 79
Search research articles
Search
Showing results (71-80 of 787) with videos related to
Sort By:
Page
of 79
Clinical Biochemistry
|
December 1, 1989
A double monoclonal time-resolved immunofluorometric assay of carcinoembryonic antigen in serum
V Bhayana, E P Diamandis
Biological Chemistry
|
July 17, 2008
Human tissue kallikreins as promiscuous modulators of homeostatic skin barrier functions
Azza Eissa, Eleftherios P Diamandis
Nature Clinical Practice. Oncology
|
August 13, 2008
Strategies for discovering novel cancer biomarkers through utilization of emerging technologies
Vathany Kulasingam, Eleftherios P Diamandis
The Urologic Clinics of North America
|
May 1, 1997
Nonprostatic sources of prostate-specific antigen
E P Diamandis, H Yu
Clinical Chemistry and Laboratory Medicine
|
September 25, 2015
Theranos phenomenon - part 2
Michelle Li, Eleftherios P Diamandis
BMC Medicine
|
August 18, 2017
Circulating tumor DNA for personalized lung cancer monitoring
Clare Fiala, Eleftherios P Diamandis
F1000Research
|
March 24, 2018
Hubris and Sciences
Eleftherios P Diamandis, Nick Bouras
F1000Research
|
January 16, 2018
Can circulating tumor DNA be used for direct and early stage cancer detection?
Eleftherios P Diamandis, Clare Fiala
Clinical Chemistry and Laboratory Medicine
|
March 12, 2020
Circulating tumor DNA (ctDNA) is not a good proxy for liquid biopsies of tumor tissues for early detection
Clare Fiala, Eleftherios P Diamandis
BMC Medicine
|
October 29, 2020
Mutations in normal tissues-some diagnostic and clinical implications
Clare Fiala, Eleftherios P Diamandis
Page
of 79